Medication Safety in Intravenous Therapy: Compatibility of Etoposide With Frequently Drugs Used in Tumour Critical Care During Simulated Y-Site Administration [Corrigendum]
Ding H, Tong T, Liu S, Tang L, Chen Z. Drug Des Devel Ther. 2025;19:1147—1161. The authors have advised there is an error in Figure 1 on page 1151. The text “Particles > 25 µm≤25 particles/mL” should read “Partic...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-03-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/corrigendum-medication-safety-in-intravenous-therapy-compatibility-of--peer-reviewed-fulltext-article-DDDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850075788300255232 |
|---|---|
| author | Ding H Tong T Liu S Tang L Chen Z |
| author_facet | Ding H Tong T Liu S Tang L Chen Z |
| author_sort | Ding H |
| collection | DOAJ |
| description | Ding H, Tong T, Liu S, Tang L, Chen Z. Drug Des Devel Ther. 2025;19:1147—1161.
The authors have advised there is an error in Figure 1 on page 1151. The text “Particles > 25 µm≤25 particles/mL” should read “Particles > 25 µm≤ 3 particles/mL”. The correct Figure 1 is as follows.
Figure 1 Diagram of compatibility justification.
The authors apologize for this error. |
| format | Article |
| id | doaj-art-db8dfec33a874f66823d2cb7d274b3c8 |
| institution | DOAJ |
| issn | 1177-8881 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Drug Design, Development and Therapy |
| spelling | doaj-art-db8dfec33a874f66823d2cb7d274b3c82025-08-20T02:46:12ZengDove Medical PressDrug Design, Development and Therapy1177-88812025-03-01Volume 1916691670100961Medication Safety in Intravenous Therapy: Compatibility of Etoposide With Frequently Drugs Used in Tumour Critical Care During Simulated Y-Site Administration [Corrigendum]Ding HTong TLiu STang LChen ZDing H, Tong T, Liu S, Tang L, Chen Z. Drug Des Devel Ther. 2025;19:1147—1161. The authors have advised there is an error in Figure 1 on page 1151. The text “Particles > 25 µm≤25 particles/mL” should read “Particles > 25 µm≤ 3 particles/mL”. The correct Figure 1 is as follows. Figure 1 Diagram of compatibility justification. The authors apologize for this error.https://www.dovepress.com/corrigendum-medication-safety-in-intravenous-therapy-compatibility-of--peer-reviewed-fulltext-article-DDDTcompatibilityy-site administrationintravenousetoposidecritical care |
| spellingShingle | Ding H Tong T Liu S Tang L Chen Z Medication Safety in Intravenous Therapy: Compatibility of Etoposide With Frequently Drugs Used in Tumour Critical Care During Simulated Y-Site Administration [Corrigendum] Drug Design, Development and Therapy compatibility y-site administration intravenous etoposide critical care |
| title | Medication Safety in Intravenous Therapy: Compatibility of Etoposide With Frequently Drugs Used in Tumour Critical Care During Simulated Y-Site Administration [Corrigendum] |
| title_full | Medication Safety in Intravenous Therapy: Compatibility of Etoposide With Frequently Drugs Used in Tumour Critical Care During Simulated Y-Site Administration [Corrigendum] |
| title_fullStr | Medication Safety in Intravenous Therapy: Compatibility of Etoposide With Frequently Drugs Used in Tumour Critical Care During Simulated Y-Site Administration [Corrigendum] |
| title_full_unstemmed | Medication Safety in Intravenous Therapy: Compatibility of Etoposide With Frequently Drugs Used in Tumour Critical Care During Simulated Y-Site Administration [Corrigendum] |
| title_short | Medication Safety in Intravenous Therapy: Compatibility of Etoposide With Frequently Drugs Used in Tumour Critical Care During Simulated Y-Site Administration [Corrigendum] |
| title_sort | medication safety in intravenous therapy compatibility of etoposide with frequently drugs used in tumour critical care during simulated y site administration corrigendum |
| topic | compatibility y-site administration intravenous etoposide critical care |
| url | https://www.dovepress.com/corrigendum-medication-safety-in-intravenous-therapy-compatibility-of--peer-reviewed-fulltext-article-DDDT |
| work_keys_str_mv | AT dingh medicationsafetyinintravenoustherapycompatibilityofetoposidewithfrequentlydrugsusedintumourcriticalcareduringsimulatedysiteadministrationcorrigendum AT tongt medicationsafetyinintravenoustherapycompatibilityofetoposidewithfrequentlydrugsusedintumourcriticalcareduringsimulatedysiteadministrationcorrigendum AT lius medicationsafetyinintravenoustherapycompatibilityofetoposidewithfrequentlydrugsusedintumourcriticalcareduringsimulatedysiteadministrationcorrigendum AT tangl medicationsafetyinintravenoustherapycompatibilityofetoposidewithfrequentlydrugsusedintumourcriticalcareduringsimulatedysiteadministrationcorrigendum AT chenz medicationsafetyinintravenoustherapycompatibilityofetoposidewithfrequentlydrugsusedintumourcriticalcareduringsimulatedysiteadministrationcorrigendum |